Flinton Capital Management LLC grew its holdings in Steris PLC (NYSE:STE) by 19.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 11,730 shares of the medical equipment provider’s stock after buying an additional 1,904 shares during the quarter. Flinton Capital Management LLC’s holdings in Steris were worth $1,026,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Captrust Financial Advisors acquired a new stake in shares of Steris in the fourth quarter valued at $101,000. Meeder Asset Management Inc. increased its stake in shares of Steris by 1,122.4% in the fourth quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock valued at $104,000 after buying an additional 1,100 shares in the last quarter. YorkBridge Wealth Partners LLC acquired a new stake in shares of Steris in the fourth quarter valued at $113,000. Zions Bancorporation acquired a new stake in shares of Steris in the third quarter valued at $178,000. Finally, Driehaus Capital Management LLC bought a new position in Steris in the fourth quarter valued at about $241,000. Institutional investors own 89.40% of the company’s stock.

How to Become a New Pot Stock Millionaire

Steris PLC (STE) opened at $95.28 on Friday. The stock has a market capitalization of $8,067.35, a PE ratio of 33.43 and a beta of 1.17. Steris PLC has a 1-year low of $67.55 and a 1-year high of $96.43. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46.

Steris (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.05. The business had revenue of $661.90 million for the quarter, compared to analysts’ expectations of $663.17 million. Steris had a return on equity of 11.57% and a net margin of 9.42%. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.98 earnings per share. equities analysts forecast that Steris PLC will post 4.13 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, February 28th will be issued a $0.31 dividend. This is a boost from Steris’s previous quarterly dividend of $0.21. The ex-dividend date is Tuesday, February 27th. This represents a $1.24 annualized dividend and a yield of 1.30%. Steris’s dividend payout ratio (DPR) is currently 43.51%.

In other Steris news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $95.50, for a total transaction of $955,000.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Sudhir K. Pahwa sold 2,000 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $92.09, for a total value of $184,180.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 78,415 shares of company stock worth $7,178,536. 2.55% of the stock is owned by company insiders.

STE has been the topic of several recent research reports. Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a report on Friday, December 29th. Raymond James Financial reiterated a “market perform” rating and issued a $100.00 price target on shares of Steris in a report on Wednesday, January 3rd. Northcoast Research set a $102.00 price target on Steris and gave the company a “buy” rating in a report on Thursday, February 8th. Finally, KeyCorp reiterated a “buy” rating and issued a $103.00 price target on shares of Steris in a report on Thursday, February 8th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Steris has a consensus rating of “Buy” and a consensus price target of $84.80.

TRADEMARK VIOLATION NOTICE: This news story was published by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.dailypolitical.com/2018/03/18/flinton-capital-management-llc-increases-stake-in-steris-plc-ste.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.